David Kirske insider trades

Open-market stock purchases and sales by David Kirske, Chief Financial Officer at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 1, 2017.

Recent trades

DateStockTradeValue
Jun 30, 2026XFOR X4 Pharmaceuticals, IncSold$36.4K
May 12, 2026XFOR X4 Pharmaceuticals, IncSold$72.8K
Oct 29, 2025XFOR X4 Pharmaceuticals, IncBought (not open market)—

Companies traded

  • XFOR X4 Pharmaceuticals, Inc: 2 sales, last Jun 30, 2026
  • CTIC CTI Biopharma Corp: 17 sales, last Jun 26, 2023

Get free alerts when David Kirske files a new trade →